Hospital acquired infections, nosocomial pathogens or 'superbugs' are increasingly becoming a major issue for senior clinicians and administrators in hospitals around the world. Bioquell’s technology is proven to be effective against a wide range of environmentally associated nosocomial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile, vancomycin-resistant enterococci (VRE), Klebsiella, Acinetobacter and other Gram-negatives. Our technology can be deployed in a variety ways to suit your particular needs. You can choose from equipment purchase or service decontamination, each offering unique benefits in a challenging and demanding setting.
The video below illustrates how Bioquell's hydrogen peroxide vapor (HPV) technology in used in a hospital setting.